Ligand profile
PSU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3750 — translation elongation factor Tu
Identifiers
Database identifiers and provenance.
- Ligand ID
PSU- PDB
5afi- UniProt (similar protein)
P0CE48- Target protein
- VK055_3750
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 182.2
- −1 ≤ LogP ≤ 5 -2.67
- MW ≤ 500 Da 324.2
- LogP ≤ 5 -2.67
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 182.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1=C(C(=O)NC(=O)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OC1=C(C(=O)NC(=O)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O
InChI=1S/C9H13N2O9P/c12-5-4(2-19-21(16,17)18)20-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H2,16,17,18)(H2,10,11,14,15)/t4-,5-,6-,7+/m1/s1InChI=1S/C9H13N2O9P/c12-5-4(2-19-21(16,17)18)20-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H2,16,17,18)(H2,10,11,14,15)/t4-,5-,6-,7+/m1/s1
MOBMOJGXNHLLIR-GBNDHIKLSA-NMOBMOJGXNHLLIR-GBNDHIKLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00237
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PSU →
- PDB RCSB structure 5afi →
- UniProt UniProt P0CE48 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PSU”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3750.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).